In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

In the test, the chemicals leaching off of the device are compared with a searchable database that provides background on toxicity and the Cramer classification. The proposed change in the standard ...

New standards may help push more drugmakers to use a synthetic product for critical drug safety testing, instead of one made from horseshoe crab blood that has long drawn criticism. The U.S.

Who pays and how much? Those are among the lingering questions about President Joe Biden's new rules requiring that many employers test their workers for COVID-19 weekly if they decline his ...

DUBLIN--(BUSINESS WIRE)--The "Animal Testing and Non-Animal Alternative Testing Global Market Opportunities and Strategies to 2035" report has been added to ResearchAndMarkets.com's offering. This ...

The global non-animal alternative testing market size was US$ 9.8 billion in 2021. The global non-animal alternative testing market is expected to grow to US$ 25.4 billion by 2030 by registering a ...

What part does sleep disturbance play in post-cancer fatigue? Findings from a prospective cohort study. Residual cancer burden (RCB) in breast cancer patients treated with taxane- and ...